Global DNA Transfection Reagents Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global DNA Transfection Reagents Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Transfection is a common laboratory cell culture technique used in many research areas, drug discovery, and development.

DNA Transfection is the process of introducing DNA into eukaryotic cells. Using various biological or physical chemical methods, this gene transfer method enables the study of gene function and protein expression in a cellular environment. The reagents used in this procedure are referred to as DNA transfection reagents.

Market Overview:

The latest research study on the global DNA Transfection Reagents market finds that the global DNA Transfection Reagents market reached a value of USD 306.7 million in 2022. It’s expected that the market will achieve USD 527.14 million by 2028, exhibiting a CAGR of 9.45% during the forecast period.

Growth Drivers

The development of DNA transfection technology has exerted great influence on modern molecular biology. Gene transfection technology is not only an important tool to study transgene and gene expression, but also a key step of gene therapy. Gene therapy is a biomedical high-tech that introduces human normal genes or therapeutic genes into human target cells in a certain way to correct gene defects or play a therapeutic role, so as to achieve the purpose of treating diseases. The introduction of exogenous genes into biological cells must rely on certain technical methods or vectors. Adenovirus vector is one of the most commonly used viral vectors in gene therapy. Gene therapy is mainly used to treat diseases that pose a serious threat to human health, including genetic diseases (such as hemophilia, cystic fibrosis, familial hypercholesterolemia, etc.), malignant tumors, cardiovascular diseases and infectious diseases (such as AIDS, rheumatoid diseases, etc.).
In recent years, the application of gene therapy in various pathological conditions such as genetic diseases and cancer has increased significantly. With the increase of disease burden, the demand for diagnosis and treatment also increases. Pharmaceutical companies and research institutions have increased their investment and research on this therapy, and because of the high requirements for transfection reagents and equipment in this research process, it is helpful to promote the growth of DNA transfection reagent market.

Region Overview:

From 2023-2028, North America is estimated to witness robust growth prospects.

Company Overview:

Thermo Fisher Scientific is one of the major players operating in the DNA Transfection Reagents market, holding a share of 28.94% in 2022.

Thermo Fisher Scientific Inc. is the world leader in serving science. Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Segmentation Overview:

Among different product types, Biological Method segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Fundamental Research segment occupied the biggest share from 2018 to 2022.

Key Companies in the global DNA Transfection Reagents market covered in Chapter 3:

Mirus Bio
Polyplus-transfection
Bio-Rad Laboratories
OriGene Technologies Inc.
Abace Biotechnology
SignaGen Laboratories
Thermo Fisher Scientific
PromoCell GmbH
Promega
Sino Biological
Roche
Horizon Discovery Ltd.
Qiagen

In Chapter 4 and Chapter 14.2, on the basis of types, the DNA Transfection Reagents market from 2018 to 2029 is primarily split into:

Biological Method
Physical Chemical Method

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the DNA Transfection Reagents market from 2018 to 2029 covers:

Fundamental Research
Drug Research and Development
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)